PMC:7074432 / 5751-6036 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"206","span":{"begin":107,"end":134},"obj":"Gene"},{"id":"207","span":{"begin":172,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A206","pred":"tao:has_database_id","subj":"206","obj":"Gene:7124"},{"id":"A207","pred":"tao:has_database_id","subj":"207","obj":"MESH:D010431"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Other Therapies\nOther treatment options, which are either used rarely or in experimental state, are SiRNA, tumor necrosis factor-alpha inhibitors, neutralizing antibodies, pentoxifylline, etc., However, the level of evidence is quite poor and hence not recommended for routine care.[8]"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T214","span":{"begin":100,"end":105},"obj":"SO:0000646"},{"id":"T213","span":{"begin":107,"end":134},"obj":"PR:000000134"},{"id":"T212","span":{"begin":135,"end":145},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T211","span":{"begin":160,"end":170},"obj":"GO:0042571"},{"id":"T210","span":{"begin":172,"end":186},"obj":"CHEBI:7986;CHEBI:7986"}],"text":"Other Therapies\nOther treatment options, which are either used rarely or in experimental state, are SiRNA, tumor necrosis factor-alpha inhibitors, neutralizing antibodies, pentoxifylline, etc., However, the level of evidence is quite poor and hence not recommended for routine care.[8]"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T28","span":{"begin":107,"end":112},"obj":"Disease"}],"attributes":[{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"Other Therapies\nOther treatment options, which are either used rarely or in experimental state, are SiRNA, tumor necrosis factor-alpha inhibitors, neutralizing antibodies, pentoxifylline, etc., However, the level of evidence is quite poor and hence not recommended for routine care.[8]"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T25","span":{"begin":107,"end":134},"obj":"http://purl.obolibrary.org/obo/PR_000000134"}],"text":"Other Therapies\nOther treatment options, which are either used rarely or in experimental state, are SiRNA, tumor necrosis factor-alpha inhibitors, neutralizing antibodies, pentoxifylline, etc., However, the level of evidence is quite poor and hence not recommended for routine care.[8]"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T70","span":{"begin":129,"end":134},"obj":"Chemical"},{"id":"T71","span":{"begin":135,"end":145},"obj":"Chemical"}],"attributes":[{"id":"A70","pred":"chebi_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/CHEBI_30216"},{"id":"A71","pred":"chebi_id","subj":"T71","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"Other Therapies\nOther treatment options, which are either used rarely or in experimental state, are SiRNA, tumor necrosis factor-alpha inhibitors, neutralizing antibodies, pentoxifylline, etc., However, the level of evidence is quite poor and hence not recommended for routine care.[8]"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T4","span":{"begin":113,"end":121},"obj":"http://purl.obolibrary.org/obo/GO_0070265"},{"id":"T5","span":{"begin":113,"end":121},"obj":"http://purl.obolibrary.org/obo/GO_0019835"},{"id":"T6","span":{"begin":113,"end":121},"obj":"http://purl.obolibrary.org/obo/GO_0008219"},{"id":"T7","span":{"begin":113,"end":121},"obj":"http://purl.obolibrary.org/obo/GO_0001906"}],"text":"Other Therapies\nOther treatment options, which are either used rarely or in experimental state, are SiRNA, tumor necrosis factor-alpha inhibitors, neutralizing antibodies, pentoxifylline, etc., However, the level of evidence is quite poor and hence not recommended for routine care.[8]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T33","span":{"begin":0,"end":15},"obj":"Sentence"},{"id":"T34","span":{"begin":16,"end":285},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Other Therapies\nOther treatment options, which are either used rarely or in experimental state, are SiRNA, tumor necrosis factor-alpha inhibitors, neutralizing antibodies, pentoxifylline, etc., However, the level of evidence is quite poor and hence not recommended for routine care.[8]"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T9","span":{"begin":107,"end":112},"obj":"Phenotype"}],"attributes":[{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Other Therapies\nOther treatment options, which are either used rarely or in experimental state, are SiRNA, tumor necrosis factor-alpha inhibitors, neutralizing antibodies, pentoxifylline, etc., However, the level of evidence is quite poor and hence not recommended for routine care.[8]"}

{"project":"2_test","denotations":[{"id":"32201439-17597972-47219426","span":{"begin":283,"end":284},"obj":"17597972"},{"id":"T4899","span":{"begin":283,"end":284},"obj":"17597972"}],"text":"Other Therapies\nOther treatment options, which are either used rarely or in experimental state, are SiRNA, tumor necrosis factor-alpha inhibitors, neutralizing antibodies, pentoxifylline, etc., However, the level of evidence is quite poor and hence not recommended for routine care.[8]"}